AI-Driven EEG Diagnostics for Rapid and Informed Neurologic Care
Ceribell with Clarity® AI brings trusted, real-time EEG diagnostics to the bedside, ensuring fast and accurate detection of status epilepticus, empowering clinicians to make decisive and effective treatment choices
Clarity, the Ceribell machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder, including automatic alerts in the event of non-convulsive status epilepticus.
At the bedside, Clarity delivers 24/7 continuous EEG monitoring and alerts:
Remotely, Clarity provides:
Real-time medication effectiveness
Easily annotate medications at the bedside with just a touch
Intuitive medication response monitoring can enable treatment optimization in real-time
How does Clarity Work?
Clarity is a machine-learning, cloud-based AI algorithm that interprets the EEG every 10 seconds across all EEG channels to provide a seizure burden estimate.3
Seizure burden is the amount of seizure activity detected in the prior 5-minute window. Prolonged seizures, such as status epilepticus, which is associated with poor neurological outcomes, display a high seizure burden.Key Features and Capabilities
- Automatically detects suspected status epilepticus at the bedside
- Continuously monitors the EEG for seizure burden
- Trained on thousands of EEG annotated by epileptologist experts and is continuously improving
- Studies generally demonstrate that the Clarity algorithm is specific and sensitive in detecting non-convulsive status epilepticus3,4
Practical Considerations
- EEG offers one component of diagnostic insight. The decision to administer treatment, or not, should consider the combination of clinical history, patient presentation, and objective data.
- Inter-rater variability of EEG diagnoses is well documented among expert readers. Since Clarity AI is trained based on expert input, a degree of inter-rater variability between Clarity AI’s output and the interpretation of the same case by a skilled neurologist should be expected.
- The capability and accuracy of the Clarity AI continues to improve with increased training on a growing volume of cases.
- Clarity AI is designed as an acute care tool to measure the overall burden of seizures, rather than detailed labeling of each individual epileptiform event3, since the cumulative impact of seizure activity has greater impact on acute patient management and prognosis5,6.
Ceribell® Indications, Safety & Warnings
Clarity is validated to consistently alert for suspected status epilepticus and rule-out seizure4 – on par with top epileptologists7
Resources
PAGE
Ceribell is the FIRST critical care monitoring and neurodiagnostic device to achieve both FDA Breakthrough Designation and a New Technology Add-on Payment (NTAP) code from CMS
Learn MorePRODUCT
In The News
References and Citations
1. Ceribell, Inc., (2025, April 15) [Press release]
2. Ceribell, Inc., (2025, November 24) [Press release]
3. Kamousi, B., et al. (2021) Neurocrit Care. 34(3):908-917
4. Puranik, T., et al., (2025). Neurocritical Care Society Annual Meeting Poster
5. De Marchis, G.M., et al. (2016) Neurology. 86(3):253-260
6. Payne, E.T., et al. (2014). . Brain. 137(Pt 5):1429-1438
7. Internal analysis on the Puranik, T., et al., (2025). Neurocritical Care Society Annual Meeting Poster dataset. Individual reviewer’s performance was estimated on each subset reviewed. The final Clarity performance reported is the average across all the subsets